Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001104659-20-139621

Options or other derivatives

  • Chief Executive Officer disposed of 75,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dewey Christopher C Chief Executive Officer 2020-12-22 Other disposition · Class B Common Stock −75,000 6,250,000 I
Loading xslF345X03/tm2039407d1_4.xml…